1 completed, 1 not yet recruiting. 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Not yet recruiting 1 |
| Not applicable | 1 | Completed 1 |
Follow Gary Van Guilder: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury Ischemic preconditioning, Intravenous lactate infusion, No ischemic preconditioning (control) - Metabolic Syndrome, Vascular Injury | Early Phase 1 | Not yet recruiting | Gary Van Guilder | 68 | 2026-10-01 | 2025-02-13 |
| The Dose-response Effects of High Intensity Functional Training on Metabolic Syndrome Risk Factors HIFT 1x/week, HIFT 2x/week, HIFT 3x/week - Metabolic Syndrome, Atherogenic Dyslipidemia | Not applicable | Completed | Gary Van Guilder | 25 | 2022-09-01 | 2024-04-23 |
Metabolic Syndrome (2) · Hyperemia (1) · Insulin Resistance (1) · Motor Activity (1) · Reperfusion Injury (1) · Vascular System Injuries (1)
United States (2)
Lance C Dalleck, PhD (1) · Nigel Harris, PhD (1)